{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:19:33Z","timestamp":1791674373563,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41416-018-0049-2","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T14:20:48Z","timestamp":1524752448000},"page":"1302-1312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine"],"prefix":"10.1038","volume":"118","author":[{"given":"Michael","family":"Herfs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Roncarati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Koopmansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Peulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Bruyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alizee","family":"Lebeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Hendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Poncin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Penny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Piazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Monnien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guenat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Mougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Pr\u00e9tet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucine","family":"Vuitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Segers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Valmary-Degano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Delvenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"49_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/s-0031-1272824","volume":"24","author":"D Leonard","year":"2011","unstructured":"Leonard, D., Beddy, D. & Dozois, E. J. Neoplasms of anal canal and perianal skin. Clin. Colon Rectal Surg. 24, 54\u201363 (2011).","journal-title":"Clin. Colon Rectal Surg."},{"key":"49_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/path.4858","volume":"241","author":"M Herfs","year":"2017","unstructured":"Herfs, M. et al. Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. J. Pathol. 241, 522\u2013533 (2017).","journal-title":"J. Pathol."},{"key":"49_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/modpathol.2015.54","volume":"28","author":"EJ Yang","year":"2015","unstructured":"Yang, E. J. et al. Microanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk. Mod. Pathol.: Off. J. US Can. Acad. Pathol. Inc. 28, 994\u20131000 (2015).","journal-title":"Mod. Pathol.: Off. J. US Can. Acad. Pathol. Inc."},{"key":"49_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.humpath.2012.08.019","volume":"44","author":"S Valmary-Degano","year":"2013","unstructured":"Valmary-Degano, S. et al. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Hum. Pathol. 44, 992\u20131002 (2013).","journal-title":"Hum. Pathol."},{"key":"49_CR5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/bjc.2015.20","volume":"112","author":"D Meulendijks","year":"2015","unstructured":"Meulendijks, D. et al. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Br. J. Cancer 112, 1358\u20131366 (2015).","journal-title":"Br. J. Cancer"},{"key":"49_CR6","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","volume":"32","author":"E Serup-Hansen","year":"2014","unstructured":"Serup-Hansen, E. et al. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 32, 1812\u20131817 (2014).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"49_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James, R. D. et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial. Lancet Oncol. 14, 516\u2013524 (2013).","journal-title":"Lancet Oncol."},{"key":"49_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0002-9610(99)80143-3","volume":"169","author":"M Basik","year":"1995","unstructured":"Basik, M., Rodriguez-Bigas, M. A., Penetrante, R. & Petrelli, N. J. Prognosis and recurrence patterns of anal adenocarcinoma. Am. J. Surg. 169, 233\u2013237 (1995).","journal-title":"Am. J. Surg."},{"key":"49_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0360-3016(03)00277-3","volume":"56","author":"Y Belkacemi","year":"2003","unstructured":"Belkacemi, Y. et al. Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network. Int. J. Radiat. Oncol. Biol. Phys. 56, 1274\u20131283 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"49_CR10","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/DCR.0b013e3181a79589","volume":"52","author":"GJ Chang","year":"2009","unstructured":"Chang, G. J. et al. A twenty-year experience with adenocarcinoma of the anal canal. Dis. Colon. Rectum 52, 1375\u20131380 (2009).","journal-title":"Dis. Colon. Rectum"},{"key":"49_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0360-3016(02)04118-4","volume":"55","author":"M Papagikos","year":"2003","unstructured":"Papagikos, M. et al. Chemoradiation for adenocarcinoma of the anus. Int. J. Radiat. Oncol. Biol. Phys. 55, 669\u2013678 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"49_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF02053944","volume":"36","author":"ME Abel","year":"1993","unstructured":"Abel, M. E., Chiu, Y. S., Russell, T. R. & Volpe, P. A. Adenocarcinoma of the anal glands. Results of a survey. Dis. Colon. Rectum 36, 383\u2013387 (1993).","journal-title":"Dis. Colon. Rectum"},{"key":"49_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21037\/tgh.2016.06.03","volume":"1","author":"A Purkayastha","year":"2016","unstructured":"Purkayastha, A., Sharma, N., Dutta, V., Bisht, N. & Pandya, T. Mucinous adenocarcinoma of perianal region: an uncommon disease treated with neo-adjuvant chemo-radiation. Transl. Gastroenterol. Hepatol. 1, 52 (2016).","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"49_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000446066","volume":"9","author":"M Matsunaga","year":"2016","unstructured":"Matsunaga, M. et al. mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma. Case Rep. Oncol. 9, 280\u2013284 (2016).","journal-title":"Case Rep. Oncol."},{"key":"49_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.amsu.2016.01.002","volume":"6","author":"DK Chan","year":"2016","unstructured":"Chan, D. K., Chong, C. S. & Tan, K. K. Case report of an anal adenocarcinoma arising from a perineal lump. Ann. Med. Surg. 6, 23\u201325 (2016).","journal-title":"Ann. Med. Surg."},{"key":"49_CR16","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/codi.12325","volume":"15","author":"S Anwar","year":"2013","unstructured":"Anwar, S., Welbourn, H., Hill, J. & Sebag-Montefiore, D. Adenocarcinoma of the anal canal\u2014a systematic review. Colorectal Dis.: Off. J. Assoc. Coloproctology Gt. Br. Irel. 15, 1481\u20131488 (2013).","journal-title":"Colorectal Dis.: Off. J. Assoc. Coloproctology Gt. Br. Irel."},{"key":"49_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ciresp.2013.01.002","volume":"91","author":"M Ferrer Marquez","year":"2013","unstructured":"Ferrer Marquez, M., Velasco Albendea, F. J., Belda Lozano, R., Berenguel Ibanez Mdel, M. & Reina Duarte, A. Adenocarcinoma of the anal canal. Narrative review. Cir. Esp. 91, 281\u2013286 (2013).","journal-title":"Cir. Esp."},{"key":"49_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/PAS.0b013e3182989ee2","volume":"37","author":"M Herfs","year":"2013","unstructured":"Herfs, M. et al. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am. J. Surg. Pathol. 37, 1311\u20131318 (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"49_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/path.4435","volume":"234","author":"P Hubert","year":"2014","unstructured":"Hubert, P. et al. Altered alpha-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral\/tumour-permissive microenvironment. J. Pathol. 234, 464\u2013477 (2014).","journal-title":"J. Pathol."},{"key":"49_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/path.4533","volume":"236","author":"J Mirkovic","year":"2015","unstructured":"Mirkovic, J. et al. Carcinogenic HPV infection in the cervical squamo-columnar junction. J. Pathol. 236, 265\u2013271 (2015).","journal-title":"J. Pathol."},{"key":"49_CR21","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2353\/ajpath.2008.071004","volume":"172","author":"M Herfs","year":"2008","unstructured":"Herfs, M. et al. Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. Am. J. Pathol. 172, 1391\u20131402 (2008).","journal-title":"Am. J. Pathol."},{"key":"49_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jviromet.2011.04.006","volume":"175","author":"BJ Kocjan","year":"2011","unstructured":"Kocjan, B. J., Seme, K. & Poljak, M. Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens. J. Virol. Methods 175, 117\u2013119 (2011).","journal-title":"J. Virol. Methods"},{"key":"49_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1128\/JCM.40.3.863-867.2002","volume":"40","author":"S Nagao","year":"2002","unstructured":"Nagao, S. et al. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J. Clin. Microbiol. 40, 863\u2013867 (2002).","journal-title":"J. Clin. Microbiol."},{"key":"49_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1200\/JCO.2005.02.7227","volume":"24","author":"O Buhard","year":"2006","unstructured":"Buhard, O. et al. Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumours. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 24, 241\u2013251 (2006).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"49_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1155\/2004\/159347","volume":"20","author":"O Buhard","year":"2004","unstructured":"Buhard, O., Suraweera, N., Lectard, A., Duval, A. & Hamelin, R. Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis. Markers 20, 251\u2013257 (2004).","journal-title":"Dis. Markers"},{"key":"49_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar, A. et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96, 261\u2013268 (2004).","journal-title":"J. Natl. Cancer Inst."},{"key":"49_CR27","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1093\/nar\/gni072","volume":"33","author":"C Mund","year":"2005","unstructured":"Mund, C. et al. Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines. Nucleic Acids Res. 33, e73 (2005).","journal-title":"Nucleic Acids Res."},{"key":"49_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","volume":"359","author":"CS Karapetis","year":"2008","unstructured":"Karapetis, C. S. et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med. 359, 1757\u20131765 (2008).","journal-title":"N. Engl. J. Med."},{"key":"49_CR29","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1158\/1078-0432.CCR-16-2738","volume":"23","author":"JM Xu","year":"2017","unstructured":"Xu, J. M. et al. PIK3CA mutations contribute to acquired cetuximab resistance in patients with metastatic colorectal cancer. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 23, 4602\u20134616 (2017).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"49_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/onc.2010.456","volume":"30","author":"V Karantza","year":"2011","unstructured":"Karantza, V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 30, 127\u2013138 (2011).","journal-title":"Oncogene"},{"key":"49_CR31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.5858\/2008-132-1547b-ICOAGC","volume":"132","author":"JB Carpenter","year":"2008","unstructured":"Carpenter, J. B. & Rennels, M. A. Immunophenotypic characteristics of anal gland carcinoma. Arch. Pathol. Lab. Med. 132, 1547\u20131548 (2008).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"49_CR32","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.5858\/2007-131-1304-ICOAGC","volume":"131","author":"M Lisovsky","year":"2007","unstructured":"Lisovsky, M. et al. Immunophenotypic characterisation of anal gland carcinoma: loss of p63 and cytokeratin 5\/6. Arch. Pathol. Lab. Med. 131, 1304\u20131311 (2007).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"49_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijscr.2014.02.010","volume":"5","author":"T Sakamoto","year":"2014","unstructured":"Sakamoto, T. et al. Adenocarcinoma arising from an anal gland-Report of a case. Int. J. Surg. Case Rep. 5, 234\u2013236 (2014).","journal-title":"Int. J. Surg. Case Rep."},{"key":"49_CR34","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","volume":"80","author":"M Durst","year":"1983","unstructured":"Durst, M., Gissmann, L., Ikenberg, H. & zur Hausen, H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA 80, 3812\u20133815 (1983).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"49_CR35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C Martel de","year":"2017","unstructured":"de Martel, C., Plummer, M., Vignat, J. & Franceschi, S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. International journal of cancer. J. Int. Cancer 141, 664\u2013670 (2017).","journal-title":"J. Int. Cancer"},{"key":"49_CR36","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","volume":"27","author":"EC Pirog","year":"2014","unstructured":"Pirog, E. C. et al. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod. Pathol.: Off. J. US Can. Acad. Pathol. Inc. 27, 1559\u20131567 (2014).","journal-title":"Mod. Pathol.: Off. J. US Can. Acad. Pathol. Inc."},{"key":"49_CR37","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/ajg.2013.94","volume":"108","author":"S Rajendra","year":"2013","unstructured":"Rajendra, S. et al. Transcriptionally active human papillomavirus is strongly associated with Barrett\u2019s dysplasia and esophageal adenocarcinoma. Am. J. Gastroenterol. 108, 1082\u20131093 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"49_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/v9040085","volume":"9","author":"M Herfs","year":"2017","unstructured":"Herfs, M., Soong, T. R., Delvenne, P. & Crum, C. P. Deciphering the multifactorial susceptibility of mucosal junction cells to HPV infection and related carcinogenesis. Viruses 9, 4 (2017).","journal-title":"Viruses"},{"key":"49_CR39","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/cas.12287","volume":"104","author":"H Wang","year":"2013","unstructured":"Wang, H., Sun, R., Lin, H. & Hu, W. H. P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects. Cancer Sci. 104, 1553\u20131559 (2013).","journal-title":"Cancer Sci."},{"key":"49_CR40","first-page":"275","volume":"29","author":"T Goto","year":"2009","unstructured":"Goto, T. et al. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Anticancer Res. 29, 275\u2013277 (2009).","journal-title":"Anticancer Res."},{"key":"49_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4161\/epi.27956","volume":"9","author":"F Coppede","year":"2014","unstructured":"Coppede, F. et al. Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism. Epigenetics 9, 621\u2013633 (2014).","journal-title":"Epigenetics"},{"key":"49_CR42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ctrv.2012.12.011","volume":"39","author":"V Heinemann","year":"2013","unstructured":"Heinemann, V., Douillard, J. Y., Ducreux, M. & Peeters, M. Targeted therapy in metastatic colorectal cancer -- an example of personalised medicine in action. Cancer Treat. Rev. 39, 592\u2013601 (2013).","journal-title":"Cancer Treat. Rev."},{"key":"49_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3816\/CCC.2007.n.011","volume":"6","author":"J Berlin","year":"2007","unstructured":"Berlin, J. et al. Panitumumab with irinotecan\/leucovorin\/5-fluorouracil for first-line treatment of metastatic colorectal cancer. Clin. Colorectal Cancer 6, 427\u2013432 (2007).","journal-title":"Clin. Colorectal Cancer"},{"key":"49_CR44","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa071834","volume":"357","author":"DJ Jonker","year":"2007","unstructured":"Jonker, D. J. et al. Cetuximab for the treatment of colorectal cancer. N. Engl. J. Med. 357, 2040\u20132048 (2007).","journal-title":"N. Engl. J. Med."},{"key":"49_CR45","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1002\/cncr.28288","volume":"119","author":"AA Wright","year":"2013","unstructured":"Wright, A. A. et al. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix. Cancer 119, 3776\u20133783 (2013).","journal-title":"Cancer"},{"key":"49_CR46","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","volume":"61","author":"M Yamauchi","year":"2012","unstructured":"Yamauchi, M. et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61, 847\u2013854 (2012).","journal-title":"Gut"},{"key":"49_CR47","first-page":"1432","volume":"342","author":"J Couzin-Frankel","year":"2013","unstructured":"Couzin-Frankel, J. Breakthrough of the year 2013. Cancer Immunother. Sci. 342, 1432\u20131433 (2013).","journal-title":"Cancer Immunother. Sci."},{"key":"49_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.molmed.2009.04.002","volume":"15","author":"M Herfs","year":"2009","unstructured":"Herfs, M., Hubert, P. & Delvenne, P. Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? Trends Mol. Med. 15, 245\u2013253 (2009).","journal-title":"Trends Mol. Med."},{"key":"49_CR49","doi-asserted-by":"crossref","first-page":"FSO88","DOI":"10.4155\/fso.15.88","volume":"2","author":"SE Matlung","year":"2016","unstructured":"Matlung, S. E., Wilhelmina van Kempen, P. M., Bovenschen, N., van Baarle, D. & Willems, S. M. Differences in T-cell infiltrates and survival between HPV+ and HPV\u2212 oropharyngeal squamous cell carcinoma. Future Sci. 2, FSO88 (2016).","journal-title":"Future Sci."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0049-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0049-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0049-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T09:43:09Z","timestamp":1720258989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-018-0049-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1038\/s41416-018-0049-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"11 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethical committee of the University Hospital of Liege has approved the use of human material (paraffin-embedded specimens) in the present study (reference number: B707201420593). The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}